Baykara, M. Et Al. 2012. Gemcitabine Plus Paclitaxel as Second-line Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.10 , 5119-5124.

Baykara, M., Coskun, U., Berk, V., Ozkan, M., Kaplan, M. A., Benekli, M., ... Karaca, H.(2012). Gemcitabine Plus Paclitaxel as Second-line Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.10, 5119-5124.

Baykara, Meltem Et Al. "Gemcitabine Plus Paclitaxel as Second-line Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.10, 5119-5124, 2012

Baykara, Meltem Et Al. "Gemcitabine Plus Paclitaxel as Second-line Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.10, pp.5119-5124, 2012

Baykara, M. Et Al. (2012) . "Gemcitabine Plus Paclitaxel as Second-line Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.10, pp.5119-5124.

@article{article, author={Meltem Baykara Et Al. }, title={Gemcitabine Plus Paclitaxel as Second-line Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2012, pages={5119-5124} }